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Abstract
In this paper, an empirical review of 64 teen tobacco use cessation studies is provided. Examined
include program contents, delivery modalities, number of contacts, and expected quit rates. In
addition, means of recruitment and retention of smokers in programming are discussed. Also,
promising contemporary methods of teen smoking cessation are examined, including use of
pharmacologic adjuncts, electronic technology, and cigarette price increases (and no smoking
policy). Conclusions are made regarding implications for developing and implementing teen
tobacco use cessation programs.
Introduction
Tobacco use is the most prevalent lifestyle-related cause of
death worldwide [1,2]. Investigation of the prevalence of
a regular pattern of tobacco use is illuminating. Daily cig-
arette smoking prevalence in the United States increases
from approximately 4% among 12 year olds, to 8%
among 16 year olds, 12% among 18 year olds, 15%
among 20 year olds, and levels off among 26 year olds at
22%, and then drops by 4% among older age groups [3].
A similar pattern of regular smoking develops among
youth in other countries, with some variation in the age
range and steepness in increase [4]. The relatively steep
daily smoking inflexion curve evident during the teen
years supports the assertion that teen tobacco use cessa-
tion programming is needed among the world's youth [5]
(also see http://www.globaltreatmentpartnership.org/
treatment_case.html, accessed on 12-20-07). In addition,
internationally approximately 60%–85% of young
tobacco users are likely to have made at least one quit
attempt and failed [6-12]. It appears that youth do want
to quit tobacco use, and most appear unable to quit on
willpower alone [13].
There have been 8 systematic reviews of the teen smoking
cessation literature thus far. First, Sussman, Lichtman,
Ritt, and Pallonen [14] evaluated 34 programs, 17 smok-
ing cessation trials and 17 smoking prevention trials for
their impact on cessation of cigarette smoking. Sussman
[15] provided an enlarged review of 66 cessation trials
(which included single-subject designs), and 17 studies of
self-initiated quitting. McDonald et al. [16] provided a re-
review of the Sussman [15] study. Garrison et al. [17]
reviewed 6 studies of relatively rigorous designs. Back-
inger et al. [18] did a qualitative review of prevention and
cessation programs.
Then, Sussman, Sun, & Dent [10] completed the first for-
mal meta-analysis of 48 studies, which included both
experimental and quasi-experimental designs. Shortly
thereafter Grimshaw & Stanton [19] provided a 2006
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Cochrane meta-analysis of 15 studies. These two studies
considered the previous studies from the previous
reviews. Both meta-analyses included the same types of
studies (randomized control trials, cluster-randomized
control trials, and controlled trials [non-randomized]).
Also, in both studies pregnant females were excluded such
that both males and female participants were represented.
However, in the Sussman, Sun, & Dent [10] meta-analysis,
the comparison group had to be a minimally active stand-
ard care or no-treatment control group. (The Moolchan et
al., [20] 2005 study was included as an exception; it
included an active cognitive-behavioral plus placebo nic-
otine adjunct control group. This study was removed from
the present analysis since the present analysis assesses
only effects beyond standard care or minimal program-
ming, not incremental effects of a component.) In the
Grimshaw & Stanton study, the comparison condition
could be an "active" or "control" condition. On the other
hand, only a quit point was needed for inclusion in the
Sussman and colleagues meta-analysis (including end of
program or follow-up), whereas a minimum of 6-months
follow-up was a standard for inclusion in the other meta-
analysis.
Both meta-analyses reached the same general conclusions,
which were similar to the other reviews; that is, it
appeared that some combination of motivation and cog-
nitive behavioral strategies provided efficacious teen ces-
sation results, whereas pharmacologic treatments did not,
although much more research was needed. Finally, Ger-
vais and colleagues [7] provided an empirical review of 16
randomized controlled trials (RCTs) derived from previ-
ous reviews and data searches up to November, 2006, and
they provided the same general results.
In the present paper, a 9th review is provided. Among the
variables examined include the most effective tobacco use
cessation program contents, modalities of delivery,
number of contacts, and expected quit rates at follow-ups.
In addition, means of recruitment and retention of smok-
ers into programming, and suggestions on the lead time
needed for a measurable effect, are discussed. In addition,
some promising contemporary methods of teen smoking
cessation are examined. These include use pharmacologic
adjuncts, use of computers or other electronic technology,
and use of cigarette price increases. The hope is that the
information in this review will have implications for
development, implementation and evaluation of teen ces-
sation programming worldwide.
Description of the 64 controlled studies in the 
present review
Study selection
The general protocol of locating studies was through mul-
tiple sources. We compiled searches of PsycINFO, Med-
INFO, the Google web engine (using the terms "teen",
"adolescent", "tobacco use", "smoking", cessation", "pro-
grams"), and word of mouth. The duration of that search
was from January, 1970 through December 2007.
Included was any article or report in the English language
that included data regarding the contents of a teen smok-
ing cessation effort, quit rates, and a through-study age
range of 12 to 19 years old. Studies that included fewer
than 8 cigarette smokers at baseline were excluded due to
extremely small sample size (less than 5 smokers per con-
dition). Tobacco related interventions for pregnant
females were not included, so that all studies involved
both genders as subjects. Data that might be available
through surveys of practitioners in the field was not
selected.
Finally, only studies that included a control condition
were selected. A total of 130 studies were located; only 64
of these studies were controlled trials. These included 47
of the 48 controlled trials from Sussman, Sun, & Dent [10]
(the Moochan study was deleted because it did not
include a minimal program control condition), 3 studies
from the Grimshaw & Stanton [19] review that were not
contained in the concurrent review [21-23], and 14 addi-
tional studies located subsequently to both of these
reviews [24-37]. The data used for the present analysis and
abbreviated references for these 64 studies are contained
in an additional text file [see Additional file 1].
What has been completed outside of the U.S. and where
One limitation of a review of teen tobacco use cessation
programs is that relatively few studies have been con-
ducted compared to adult cessation programs [1], and
even fewer teen tobacco use cessation studies have been
conducted outside the United States. In the present study
64 controlled teen cessation programs are examined, and
17 studies were completed outside of the U.S. Of these
studies, 4 were from Australia, 3 were from Canada, 1 was
from China, 1 was from Finland, 2 were from New Zea-
land, 1 was from Singapore, 1 was from Switzerland, and
4 were from the UK. Among the 8 countries outside of the
U.S. that conducted published teen cessation work in Eng-
lish, aside from the study in China, all were high per cap-
ita income countries. Results have failed to be found to
vary systematically by whether or not data are from the
U.S. or not [10,15].
Adequacy of designs, data quality and collection for the 
present review
Research designs
The review discerned the difference between treatment
group quit rates and naturally occurring or comparison
group minimal treatment quit rates (e.g., standard care)
[38,39]. One method of doing this is through use of ran-
domized designs, in which groups are assigned to condi-Tobacco Induced Diseases 2009, 5:3 http://www.tobaccoinduceddiseases.com/content/5/1/3
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tions (program versus control group) based on a "flip of a
coin." This design best controls for confounders that
might interfere with interpretation of results. The World
Health Organization (WHO) refers to this level of evi-
dence as being "probable;" that is, the expected changes
were unlikely to have occurred by chance (32 RCTs were
located). A second kind of design includes a control group
that is not assigned randomly. This provides a crude
means of gauging what the quit rate might have been if
the program group had not received the treatment. WHO
refers to this level of evidence as "plausible;" the expected
changes that occurred were greater than could be
explained by any other external influences (31 quasi-
experimental trials were located). We also included multi-
ple-baseline designs, or other means of finding a control
group quit rate (e.g., data that aggregates quit rates from
other studies in the region). WHO describes this level of
evidence as "adequate" (only one multiple baseline trial
was located). We failed to find variation in results as a
function of level of evidence both in the Sussman, Sun, &
Dent [10] review and with inclusion of 17 additional con-
trolled studies in the present review. Thus, we do not
divide the presentation of results by level of evidence. The
overall level of evidence for the studies in this review is
within a range from plausible to probable. Studies in gen-
eral would be considered efficacy studies, being con-
ducted under ideal conditions. However, most of the
studies confronted real world settings, and might be con-
sidered effectiveness trials as such.
As mentioned previously, these 64 controlled trials were
derived from 130 total studies; 50% of the total pool of
studies uncovered lacked control conditions, and could
not be included in the review. Approximately 1/3 of the
studies post 2000 were single-group designs, suggesting
some improvement in designs of these types of studies
since that time. Also, approximately 1/3 of teen cessation
studies were published in 2000 or later (n = 42). Thus,
interest in teen cessation appears to be increasing.
While validity scores were not used in the present study or
in Sussman, Sun, & Dent [10] approximately 66% of the
studies in the current review would be considered of mod-
erate or high quality using the McDonald et al. [16] crite-
ria (theoretical fidelity, implementation compliance,
research design, sample size, and post-treatment follow-
up; ratings of 2 = high, 1 = low, and 0 = no report for each
criterion which were summed to create a validity score).
The conclusions of the McDonald et al. study were the
same as in the Sussman, Sun, & Dent [10] study.
Data quality and collection
Only 27 of 64 studies (42%) described ethnicity of subject
in the present review. The prevalence of missing data on
ethnicity was too high to include this variable in any anal-
yses. Collection of ethnicity data should become a regular
process in these studies, and programming needs to be
offered and evaluated in areas with higher racial minority
concentrations to assess generalizability of programming
to different ethnic groups.
Also, insufficient data was available to calculate reduction
in average level or duration of baseline cigarette smoking
among those who did and did not quit cigarette smoking
after receiving programming, particularly at follow-up
time points. Better measurement of current smoking
behavior is needed in these studies.
Average rate of reach to target recruitment was approxi-
mately 50%, and average retention rate was approxi-
mately 75% for follow-up. Though there was large
variation on these measures, it would appear that the data
collection was adequate considered across all studies.
Adequacy of program implementation
It would appear that program implementation is one of
the relatively strong features of published programs.
Oftentimes, programs were somewhat eclectic in con-
tents, but research teams reported that they implemented
these contents fairly well. There was little evidence pro-
vided of disruption during implementation, omitted ses-
sions, or reinvention. On the other hand, specific
documentation of fidelity of implementation was not
provided in most studies. Certainly, major changes have
occurred in program implementation. For example, NOT,
which was developed to be implemented to same sex
groups, generally is implemented to both genders in field
studies, with little apparent negative impact on results
(Dino and Horn, personal communication by program
developers, November, 2007). Most studies don't inform
the reader on provider characteristics (e.g., training, age,
and experience). None discuss issues related to cost and
feasibility of implementation. Thus, the program imple-
mentation fidelity "transparency" is not clear. Research is
needed in this domain of inquiry.
Recruitment strategies
Across the 64 studies, direct interpersonal contact of treat-
ment agent with potential participants and recruitment in
contexts that include most of its members as potential
participants (e.g., classrooms) led to relatively high reach
(over 35%). The most popular recruitment strategies were:
￿ word of mouth (n = 24 studies)
￿ public announcements (n = 17)
￿ screening (n = 17)
￿ money, movie tickets, gift certificates (n = 14)Tobacco Induced Diseases 2009, 5:3 http://www.tobaccoinduceddiseases.com/content/5/1/3
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￿ class release time (n = 12)
￿ use of posters (n = 12)
￿ media campaigns/newspaper ads (n = 9)
￿ policies such as mandatory attendance (n = 8)
￿ referrals (n = 7)
￿ flyers (n = 6)
￿ part of a classroom program (n = 6)
￿ presentation to a group (n = 5)
￿ gatekeepers' support (n = 5)
￿ use of class credit (n = 4)
￿ use of contests (n = 3)
￿ use of a display table (n = 2)
￿ social influence (n = 2)
￿ peer supporters to recruit (n = 2)
￿ use of community or school events (n = 1)
It is not possible to discern which recruitment methods
are the most effective from this pool of studies. It would
appear that use of multiple strategies work better than use
of one strategy, except in situations in which youth are
"captive audiences" (e.g., classroom program or manda-
tory attendance in a program), where recruitment is not a
major issue.
Representativeness of the data
Youngest to oldest age at baseline to last follow-up was an
average of 14 and 19 years. Baseline smoking averaged
approximately 10 cigarettes per day (cpd). The average
sample size was a mean of 414 (range 12 to 3800; sd =
588). In addition, an average of 51% of subjects was
female. In the Sussman, Sun, & Dent [10] review, in pre-
liminary analyses we failed to find bias in effect size as a
function of variability in sample size, year of publication
of study, due to random assignment or not, follow-up
retention, average level of baseline smoking (though vari-
ous studies do find lower quit rates among heavier smok-
ers [39]), country of study (U.S. or Other), gender,
ethnicity, mean age, age range, program reach, and years
data were collected. The addition of 17 studies does not
alter these results. It would appear that this data is repre-
sentative of subjects involved in these types of studies.
Variables examined in the analysis
As in Sussman, Sun, & Dent [10], we examined the mean
estimates for four main predictors of outcomes.
￿ Five types of contents: (1) social influence, (2) cognitive-
behavioral, (3) motivation, (4) medical, and (5) other
(i.e., supply reduction and affect clarification)
￿ Seven modalities: (1) classroom, (2) school-clinics, (3)
medical clinics, (4) family, (5) system-wide, (6) compu-
ter, (7) other settings (sensory deprivation, court diver-
sion, worksite, shopping mall/home, and dormitory).
￿ #Sessions: 1–4, 5–8, 9+ (3 categories)
￿ Length of follow-up: 0–3, 4–12, and > 12 months past
immediate posttest (3 categories)
We merged sensory deprivation and court diversion from
the previous study (they were treated as separate modali-
ties with one study each in the 2006 study), and we
labeled the category "other settings." In addition, we
added three new studies to this category. These were: dor-
mitory [21], shopping mall and home [22], and worksite
[34].
Smoking data was converted into cigarettes per day equiv-
alents, and was determined through self-reports. Bio-
chemical methods were applied in 38 (59%) of the
studies. A standard definition of baseline smoking and
quitting is not used across studies. In some studies quit-
ting is measured as no smoking over at least one-week
duration, whereas in other studies quitting is measured as
no smoking over the last 30 days. Variation in measures
introduces error variance, which could make it more diffi-
cult to find an effect.
Adequacy of data analysis
Most teen cessation studies were under-powered statisti-
cally; that is, the sample sizes tended to be too small to
detect differences between program and control means
with reasonable certainty [38,40]. Also, most studies
failed to use clustered analyses as they were not yet popu-
larly used with clustered data. Otherwise, previous studies
provided data analysis techniques in general that were
appropriate for the years in which they were conducted.
The primary endpoint in the present review was percent
quit-rate (P). The data entered were intent-to-treat percent
quit data. The net effect definition in this study was a risk
difference (RD); also called "absolute risk reduction." The
RD here was percentage of subjects that quit tobacco in a
program condition minus the percentage of subjects that
quit tobacco in a control condition.Tobacco Induced Diseases 2009, 5:3 http://www.tobaccoinduceddiseases.com/content/5/1/3
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Use of Intent-To-Treat (ITT) analysis was one way to deal
with attrition from studies. That is, subjects who dropped
out of the studies were considered to not have quit smok-
ing. However, ITT analysis is not without its drawbacks
when comparing conditions. ITT analysis could bias the
results if there was differential attrition by condition.
However, we failed to find differential attrition by condi-
tion averaged over the studies, so that ITT was used cor-
rectly herein.
In the Sussman, Sun, & Dent meta-analysis, data were
entered as intent-to-treat (ITT) quit rates (not compliance
sample rates), and weighted least squares random effects
models were used to pool results from study net effect esti-
mates. When pooling studies, they were weighted by sam-
ple size, and were adjusted for follow-up duration (1–3
month, 3–12 month, or greater than 12 months). Analy-
ses were supplemented with use of forest plots. The same
analyses were repeated in the present study.
Results of current review
Overall effect
The program mean estimate was 11.79 (error = 1.10, t
value = 10.72, p < .001, two-tailed), and the control mean
estimate was 7.53 (error = 1.11, t value = 6.85, p < .001,
two-tailed). The overall absolute risk reduction effect was
a program advantage of absolute effect = 4.26% (relative
increase for treatment: (11.79–7.53)/7.53 = 57% reduc-
tion). Thus, after a 27% increase in number of studies in
the pool, the overall outcomes are slightly higher than the
previous meta-analysis (2.90% advantage with n = 48),
though the effect size is still not large.
Theoretical frameworks
"Theory" refers to the theoretical content of the program.
"Modality" refers to the community unit within which the
cessation program is implemented. Collapsed across dif-
ferent modalities of programming, a total of five types of
theoretical foci were reflected in these studies [10]. These
categories were: (1) social influence, (2) cognitive-behav-
ioral, (3) motivation, (4) medical, and (5) other (i.e., sup-
ply reduction and affect clarification). The purpose of
social influence-oriented programming was to combat
social influences that serve to promote or maintain smok-
ing. Such information included refusal assertion skill
instruction, instruction in awareness of tobacco industry
promotions, media and peer social influences, and correc-
tion of social informational inaccuracies. This also
includes advocacy (activism) techniques to advocate ces-
sation by empowering teens to protest against the tobacco
industry or otherwise act directly on their social environ-
ment to induce change (e.g., trying to reduce exposure to
passive smoking).
Instruction of cognitive-behavioral coping techniques
focus on uncovering the topography of ones tobacco use
(e.g., reasons for smoking and quitting, self-monitoring)
and how to cope effectively with stress (e.g., seek out
social support, relaxation, wait out urges, self-manage-
ment, problem solving). In addition, decision making is a
key aspect of this approach, to help consider choices,
select a choice, and choose which behaviors to follow
through on.
Motivation enhancement techniques serve to clarify
desire for change and reduce ambivalence toward change.
This may include, but is not restricted to, a specific strat-
egy such as motivational interviewing. Motivation
enhancement helps participants to clarify their direction
of change and increases their willingness to change. Moti-
vation enhancement may also include use of response-
contingent reinforcement, which reinforces quit-behavior
with the chance for extrinsic rewards such as money or
prizes. Motivation-enhancement also may include stages-
of-change techniques. In Transtheoretical (stages of
change) model-based work, program material is framed
for the participants' stage of change, to help motivate sub-
jects to move through the quitting process. These pro-
grams often tend to be combined with cognitive-
behavioral material. However, a main emphasis of the
program is its inclusion of motivation enhancement.
The medical category refers to use of means to ease physi-
cal effects of withdrawal (use of pharmacological adjuncts
or substitutes), and/or emphasis on recovery from addic-
tion (e.g., 12-steps), or use of alternative medicine tech-
niques such as acupuncture.
An "Other" category includes categories that didn't fit
elsewhere; supply reduction and affect clarification
approaches. Supply reduction involves arranging the
physical environment such that tobacco is more difficult
to obtain or use (e.g., price increases or restricted access).
Affect clarification involves techniques to clarify and
remove conflicted affect, and thereby permit pursuit of
health including cigarette smoking cessation.
The cessation theory outcomes for the 64 studies revealed
the same pattern as the 2006 analysis [10], as shown in
Table 1. Effects were notable for social influences, cogni-
tive-behavioral, and motivation enhancement program-
ming. Results also appeared for medical programming
(error = 3.22, t = 4.93, p < .001), in the current analysis
since the number of studies increased from 1 to 3. How-
ever, the number of studies is too small to infer consistent
effects. Significance values from the previous study on the
three outcomes mentioned is maintained from the previ-
ous meta-analysis to this one, and one new effect
appeared albeit based on very few studies.Tobacco Induced Diseases 2009, 5:3 http://www.tobaccoinduceddiseases.com/content/5/1/3
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Modality of programming
There were 7 groupings of community units within which
the cessation program was examined. The significant
effects of classroom and school-based clinic modalities
revealed in the previous meta-analysis were maintained
with the larger sample, as depicted in Table 2. Medical set-
tings now showed a significant effect (error = 1.88, t =
2.46, p < .05). Other effects still were not significant
though computer-based programming still looks promis-
ing. Too few studies were in family (n = 1) or other set-
tings (n = 3) modalities to make confident inferences.
One limitation in trying to differentiate theory from
modality is that these are not orthogonal categorizations.
In the current sample, 7 of 11 classroom-based studies
involve social-influence manipulations, 20 of 29 school-
clinic studies are cognitive-behavioral, 8 of 9 medical
clinic studies are motivation-enhancement-based, 4 of 6
system-wide studies are in the "other" theory category,
and 2 of 3 computer-based studies are motivation-
enhancement based.
Number of sessions and length of follow-up
Relatively higher quit rates were found for programs hav-
ing at least 5 sessions (> 4 sessions, 6% increase compared
to controls). This pattern of results was maintained as in
the 2006 meta-analysis, as shown in Table 3.
Effects were maintained at short term (1 year or less) and
longer-term (> than 1 year) follow-ups in both the 2006
and present analysis, as shown in Table 4. The number of
studies examining greater than 12 month follow-ups
increased from 5 to 8 in the present analysis, and yet the
effect still held up well. More studies with longer-term fol-
low-ups are needed, though these data remain promising,
and suggest that across studies most teen cessation rates
tend not to decrease much over time. Programs targeting
teen smoking cessation do appear to be efficacious.
Examination of programs of particular 
contemporary interest
Pharmacologic adjuncts
There is a strong interest in the promise of use of pharma-
cologic adjuncts for teens since these treatment agents
have been very useful among adults [1]. This type of pro-
gramming generally is constructed as an addition to other
treatment programming such as cognitive-behavioral
treatment. That is, most of these types of trials compare an
active treatment to the active treatment plus a pharmaco-
logic adjunct. Hence, these types of designs are not con-
tained in the meta-analysis as the comparison condition is
an "active" control.
A total of 10 studies have been completed thus far (Han-
son et al. [41], Hurt et al. [42]; Killen et al. [43] [both nic-
otine patch and Buproprion were examined]; Moolchan et
al. [20] [both nicotine gum and patch were examined];
Muramoto et al. [44]; Niederhofer & Huber [45]; Roddy et
al. [46]; Smith et al. [47]; Sussman et al. [48]; Upadhyaya
and colleagues [49]). Seven of these studies utilized com-
parison groups, which were cognitive-behavioral, stand-
ard cessation counseling (including instruction of coping
skills). Unfortunately, the use of a pharmacologic adjunct
failed to show an incremental effect among teens in 5 of
Table 1: Treatment Means: 2006 and Current Analysis Stratified 
by Theory
Theory 2006 Estimate Current Estimate
Social influence (8, 11) 3.77 4.34
Cognitive-behavior (17, 22) 4.72 5.32
Motivation (15, 22) 3.66 3.97
Medical (1, 3) 13.16 15.86
Other (6, 6) -0.16 -0.17
Note. The information in parentheses indicates the number of studies 
in 2006 and then the current analysis. Moolchan et al. (2005) had used 
a medical model but this study is not included in this table's current 
estimate because it had not included a standard care control 
condition.
Table 2: Treatment Means: 2006 and Current Analysis Stratified 
by Modality
Modality 2006 Estimate Current Estimate
Classroom (7, 11) 4.15 4.21
School Clinics (25, 29) 5.62 6.30
Medical Clinics (5, 9) 2.40 4.62
Family (1, 1) 21.37 19.10
System-Wide (5, 6) -0.22 0.81
Computer (2, 3) 5.60 5.40
Other Settings (2, 5) 1.45 3.92
Note. The information in parentheses indicates the number of studies 
in 2006 and then the current analysis, 2007. Moolchan et al. (2005) 
had used a medical modality but this study is not included in the 
current estimate because it had not included a standard care control 
condition.
Table 3: Treatment Means: 2006 and Current Analysis Stratified 
by Number of Sessions
Number of sessions 2006 Estimate Current Estimate
1–4 (17, 26) -0.08 3.20
5–8 (15, 20) 6.43 6.24
9+ (15, 18) 4.47 4.20
Note. The information in parentheses indicates the number of studies 
in 2006 and then the current analysis, 2007. Moolchan et al. (2005) 
had 13 sessions but this study is not included in this table's current 
estimate because it had not included a standard care control 
condition.Tobacco Induced Diseases 2009, 5:3 http://www.tobaccoinduceddiseases.com/content/5/1/3
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the 7 comparison group trials. The mean incremental
effect at last follow-up for nicotine gum was 2.5% (2 con-
trolled studies; 4% and 1%), for nicotine patch was 4.5%
(4 controlled studies; 2%, 15%, 1%, and 0%), and for
buproprion was 13% (3 controlled studies; 1%, 1%, and
37%). Only Moolchan and colleagues found a treatment
effect for nicotine gum (4%) and the nicotine patch (15%;
6-month trial, n = 120). In addition, only Niederhofer
and colleagues found an effect for buproprion (37%; 3-
month trial, n = 22). While effects were not promising,
one study found a reduction in withdrawal symptoms
[42].
Three of the 10 studies were single-group in design
[42,47,49]; the Hurt [42] and Smith [47] studies each
revealed a 5% quit rate, examining use of the nicotine
patch; Upadhyaya and colleagues [49] revealed a 31%
quit rate after 4 weeks of taking Buproprion SR [n = 16]).
While difficult to interpret, it is not likely that an effect
was achieved in 2 of the 3 single group studies, consider-
ing naturally occurring quit rates among teens.
Even if medication was helpful with teens, Shelley et al.
[50] found that in the U.S. in 2000 only 16% of physi-
cians and 12% of dentists advised their teen smoker
patients to quit smoking. Thus, major changes in medical
settings would be needed in dissemination work.
Recently, Pfizer is testing the efficacy of varenicline, a par-
tial nicotinergic receptor agonist, with teens (http://
www.centerwatch.com/patient/drugs/dru897.html;
accessed 12-18-07). This drug has been found to be highly
effective with adults, but it will take several years to learn
whether or not it is of assistance with teens.
Effects of internet/txt messaging
Another area of current interest is in the use of electronic
communications technology to assist in teen cessation. A
total of 6 studies were located (Chen & Yeh [51]; Mermel-
stein & Turner [52]; Patten et al. [53]; Rabias et al. [54];
Rodgers et al. [33]; Tossman & Lang [55]). Only two of
these studies (Rabias et al. [54]; Rodgers et al. [33]) were
included in the 64-study review. Chen & Yeh [51] com-
pared a smoking cessation group plus internet-assisted
program instruction versus a standard care comparison
group in a 6-week pretest-posttest quasi-experimental
design consisting of a total of 77 senior high school teens
in Taiwan. The program condition resulted in a higher
reduction in rates of daily smoking (21% reduction versus
a 2.5% increase) and a greater number of quit attempts
relative to the control group (an average of 1 more quit
attempt during the 6-week period). Youth appeared favo-
rable to including the internet component. However, quit
data, or means to estimate it, was not provided in the
paper.
Mermelstein & Turner [52] found at 29 high schools (n =
351) among 14–19 year olds in a clustered-randomized
control trial that use of a school-based clinic teen tobacco
use cessation program (NOT) plus use of a website and
proactive phone calls produced marginally higher quit
rates at a 3-month follow-up than use of the clinic alone
(14% vs. 7%; 7-day quit rate).
Patten et al. [53] contrasted a 4-session office clinic-based
program (n = 139) involving motivational interviewing
and problem solving among 11–18 year olds against a
home-based internet program (Stamp Out Smokes; access
was provided for 24 weeks; 66% stopped using the inter-
net program by the 3rd week of the program) in a rand-
omized control trial. The 30-day ITT quit rates at 36 weeks
favored the office based program, 13% vs. 6%, respec-
tively, though the outcomes failed to reach statistical sig-
nificance. Tossman and Lang [55] in Germany with a
single group design found 48% quit rates among 16–18
year olds (7-day) obtained one month after quit day with
use of an individual-tailored internet program "rauchfrei"
("smoke-free").
Rabius et al. [54] contrasted 5-session telephone coun-
seling vs. self-help booklets in a randomized controlled
trial among 18–25 year olds (12% of the sample of 420
youth was still teens). At 6-month follow-up 10% vs. 3%
had quit (ITT quit rate, last 48 hours). Finally, Rodgers et
al. [33] provided a randomized controlled trial. This study
included 617 teen smokers, who received personalized
cognitive-behavioral oriented cell phone text messaging
for 1 week before and 4 weeks after quit day versus a con-
trol group (bi-monthly general text messages to keep
them involved in the study). While earlier results looked
promising (14% vs. 6% ITT at 6-weeks, 29% vs. 19% at 12
weeks), results at 6-month follow-up were not (25% vs.
24%). It appears that use of telephone counseling is
promising. Use of the internet or text messaging also may
be promising if programming is bolstered over a long
period. Much more research is needed in this arena, as
these different communication devices will begin to inter-
face and become more interactive.
Table 4: Treatment Means: 2006 and Current Analysis Stratified 
by Follow-up Duration
Follow-up Duration 2006 Estimate Current Estimate
0–3 month (36, 38) 3.88 4.17
4–12 month (21, 29) 2.92 4.06
> 12 month (5, 8) 6.62 6.78
Note. The information in parentheses indicates the number of studies 
in 2006 and then the current analysis. Moolchan et al. (2005) had a 3 
month follow-up but this study is not included in this table's current 
estimate because it had not included a standard care control 
condition.Tobacco Induced Diseases 2009, 5:3 http://www.tobaccoinduceddiseases.com/content/5/1/3
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Price of cigarettes, restrictions on smoking, and teen 
cessation
At present, we are aware of only one study that examines
the relations between price of cigarettes and teen smoking
cessation. Tauras & Chaloupka [56] completed this work,
using the Monitoring the Future High School Senior data.
These researchers reported that the price elasticity of male
cessation ranges from 1.07 to 1.17 and has an average
elasticity of 1.12. The price elasticity of female smoking
cessation ranges from 1.17 to 1.21 and has an average
elasticity of 1.19. These estimates imply that a 10%
increase in the real price of cigarettes will increase the
probability of smoking cessation by approximately 11%
and 12% for 18 year old men and women respectively
(3.5% among young adults [57]). Maybe for teens increas-
ing prices significantly reduces prevalence 6–7%
(Chaloupka, personal communication, March, 2007).
State-level policies restricting smoking in private work-
places have a positive impact on the probability of cessa-
tion among employed young adult females. Other
restrictions on smoking in public places seem to have lit-
tle impact on female smoking cessation decisions. In gen-
eral, laws restricting smoking in private worksites and
public places have no significant impact on young adult
male smoking cessation decisions [56], though Tauras
[57] did find an effect, albeit equivocal, on young adult
cessation as a function of restrictions in private worksites
and public settings other than restaurants (both genders;
weaker effect among males). There are no data on teens at
present, except for those summarized in the analysis of 64
studies which failed to find an effect.
Regarding limiting retail access to tobacco products, Chen
& Forster [58] conducted a two-group experimental study,
involving cross-sectional surveys of 8th, 9th, and 10th grad-
ers from a total of 14 communities, that demonstrated an
effect on reducing prevalence of daily smoking by mobi-
lizing community members to limit retail access to youth.
This effect was found up to a five-year follow-up; however,
cessation of smoking or other tobacco use was not
accessed.
Conclusion
Based on the empirical review of 64 programs, and review
of contemporary possibilities, we propose the following
suggestions for advancing youth cessation internationally.
First, cessation programming should be delivered in a
context which is structured for youth, such as the school,
sports club, or health clinic, because youth tend not to
impose structured situations on themselves (e.g., by keep-
ing an appointment book). Also, programming should
consist of at least 5 sessions. Also, programming should
be as fun as possible, involving games, dramatizations,
and use of alternative medicine concepts. Youth will want
to remain in a program that is interesting [4,15].
The contents of teen cessation programming should
emphasize cognitive-behavioral, motivation theory-
related, and some social influences contents. For example,
awareness of the changes that gradually occur as a func-
tion of continued smoking (e.g., increased stress,
decreased mood) and quitting (e.g., decreased stress,
improved mood) need instruction, along with means to
help motivate youth to overcome ambivalence toward
quitting. Instruction on how to avoid or counteract ciga-
rette smoking social influence situations should be
instructed. Also, methods of quitting and how to cope
with stressful situations more effectively should be
instructed. It is not clear whether programming that com-
bines all three types of programming would be superior,
or whether different programming might be relatively
effective with different youth (e.g., at different durations
of lifetime smoking) but, for the time being, it might be
best to combine elements of each. Tentatively, program-
ming that monopolizes numerous channels of communi-
cation would appear best [59]. Thus, use of classroom
based programs, or school-based clinics, supplemented
with computer based modalities, parent groups, mass
media messages, or any other modalities that could be
supported within a community, would be of most prom-
ise. Program efficacy is positively related to dosage, up to
5 cessation sessions at which point there is no apparent
incremental effect of including additional sessions.
In 2004, the U.S. DHHS published the first guide for mak-
ing informed decisions regarding teen cigarette smoking
cessation ([60]; http://www.cdc.gov/tobacco/
quit_smoking/cessation/00_pdfs/youth_tobacco_a.pdf;
accessed on December 20, 2007). The recommendations
made are consistent with the findings of the present anal-
ysis, and provide the practitioner with information on
how to select a cessation program, what contents to
include, how to implement a program, and how to evalu-
ate it. At present, there are only two Substance Abuse Men-
tal Health Services Administration (SAMHSA) model teen
cigarette smoking cessation programs, Projects NOT and
EX. Both of these projects may be purchased and utilized,
and information on them is available on the SAMSHA
model programs web site http://www.modelpro
grams.samhsa.gov. Interestingly, both programs contain
different types of motivation enhancement and cognitive-
behavioral strategies, and are at least 8 sessions in length.
These programs are consistent with this 9th analysis
regarding the components of efficacious teen smoking
cessation programming.
The present analysis suggested that programming might
best be delivered in a school-based context. However,Tobacco Induced Diseases 2009, 5:3 http://www.tobaccoinduceddiseases.com/content/5/1/3
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there are many barriers to delivering health programming
in a school context internationally, including lack of
understanding of the importance of school health pro-
grams, inadequate coordination and lack of a sense of
responsibility for student health among school staff, and
lack of resources [5]. Key areas to consider include the
logistics, cost, time, and human resources required for the
implementation of the intervention. A question for con-
sideration is whether the intervention can be imple-
mented on a large scale in a way that will be acceptable by
policy makers and the general public, sustainable and
cost-effective. Researchers will be able to better examine
effect sizes among the theories and modalities, and other
variables, when there are a greater number of studies to
represent categories, particularly when implemented and
evaluated in developing countries.
Future research should make use of appropriate controls,
use more standard measures of cessation, and conduct
longer follow ups (12 months and perhaps even longer).
Future teen smoking cessation studies also might consider
use of multiple tobacco use measures (e.g., last 24 hour,
last 7 days and last 30 days) to make comparisons consist-
ent across studies. In addition, measures of nicotine
dependence (such as the modified FTQ) should be
included to assess effectiveness of programming as a func-
tion of nicotine dependence [15]. Regular assessment also
should include collection of all types of tobacco products
used to make sure no substitution effects occur, or that
one only quits one type of tobacco use [38]. Also, metrics
like cost-effectiveness of treatment per disability/quality
of adjusted life years saved should be examined in future
teen smoking cessation studies. They may reveal greater
cost-effectiveness when compared to adult smoking cessa-
tion programs involving persons that are further along on
a disease course. Related, types of programming for
tobacco users at different levels of use should be further
explored
Teen smoking cessation programs are efficacious overall.
Also, it is interesting that many of the findings are consist-
ent with those found in the adult cigarette smoking cessa-
tion literature, particularly regarding the importance of
use of cognitive-behavioral strategies and achieving a suf-
ficient dosage of programming [1]. One difference is that,
at the present time, there is little evidence of the efficacy
of the use of pharmacologic adjuncts with youth, whereas
the evidence appears strong with adults. Future work on
the metabolism of pharmacologic adjuncts, youths' pat-
terns of tobacco use, and self-reported withdrawal symp-
toms might help one to better understand their potential
effectiveness among youth.
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